Jan 8 (Reuters) - ISRACANN BIOSCIENCES-
* ISRACANN BIOSCIENCES, AN ISRAELI-BASED CANNABIS FIRM, SAYS HAS COMPLETED A LETTER OF INTENT FOR UP TO $15 MILLION IN FUNDING
* ISRACANN BIOSCIENCES INC - ISRACANN EXPECTS TO COMMENCE TRADING IN CANADA IN 2019